[The possibilities and limitations of psychotropic drug therapy for patients with glaucoma].
D000368:Aged; D000437:Alcoholism / Q000150:complications / Q000188:drug therapy; D000639:Amitriptyline / Q000009:adverse effects*; D000928:Antidepressive Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002908:Chronic Disease; D003704:Dementia / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy; D005260:Female; D005901:Glaucoma / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008297:Male; D008728:Methotrimeprazine / Q000009:adverse effects*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000150:complications / Q000188:drug therapy; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D013881:Thioridazine / Q000009:adverse effects*; D014282:Trihexyphenidyl / Q000009:adverse effects*
D000928:Antidepressive Agents; D000639:Amitriptyline; D014282:Trihexyphenidyl; D008728:Methotrimeprazine; D013881:Thioridazine
O vozmozhnostiakh i ogranicheniiakh terapii psikhotropnymi sredstvami lits, stradaiushchikh glaukomoĭ